CIDRAP newsletters options
Massachusetts General Hospital (MGH) said today it was part of an international multisite study evaluating ZMapp, an experimental Ebola treatment. ZMapp contains three antibodies and is being used in the current outbreak in the Democratic Republic of the Congo (DRC)
Both newly reported patients belonged to families that refused Ebola vaccination, and one of them died.
As the Southern Hemisphere's flu season winds down, disease levels in temperate South American and southern Africa countries decreased or have peaked in recent weeks, according to the latest global flu update from the World Health Organization (WHO).
The results of a phase 3 randomized, controlled clinical trial show that monotherapy with the antibiotic/beta-lacatamase inhibitor combination Vabomere (meropenem-vaborbactam) in patients with carbapenem-resistant Enterobacteriaceae (CRE) infections was associated with increased clinical cure, decreased mortality, and reduced kidney toxicity compared with the best available therapy (BAT).
The outbreak grows to 159 cases, 127 of them confirmed, and 104 deaths.
The Saudi Arabian Ministry of Health (MOH) noted two more MERS-CoV cases in epidemiologic week 39 (last week) and one in epidemiologic week 38, and two of the cases proved fatal.
Researchers from the Cleveland Clinic have observed that telemedicine encounters in which antibiotics were prescribed for a respiratory tract infection (RTI) were shorter than encounters where a non-antibiotic or nothing were prescribed.
The experts also called for 3 new pandemic candidate vaccine viruses.
There are now 155 cases (124 confirmed, 31 probable), including 102 deaths, in the outbreak.
Research on the device indicates it has the potential to provide quick, low-cost diagnostics.
A new study examining racial and ethnic disparities in antimicrobial drug use in the United States shows that white people filled twice as many antibiotic drug prescriptions per capita compared with people of other races and ethnicities. The study was published yesterday in Emerging Infectious Diseases.
The Coalition for Epidemic Preparedness Innovations (CEPI) yesterday announced that it has awarded a contract worth as much as $19 million to Oxford University and Janssen Vaccines to advance the development and manufacture of a vaccine against MERS-CoV and do preclinical studies of new vaccines against Lassa and Nipah viruses.
Whole-genome sequencing could lead to faster, more accurate resistance testing.
Coverage in kids 4 and younger was 67.8% last season, down 2.2 percentage points.
The data suggest that, for the vast majority of men, Zika RNA is cleared from semen within 4 months.
A case report today from the Centers for Disease Control and Prevention (CDC) details the detection of a multidrug-resistant fungus in patients from three states.
Flu vaccine uptake in UK seniors has been high in recent flu seasons, but vaccine effectiveness (VE) has been modest in this age-group and the vaccine has been ineffective against the most severe strain, according to a study today in Eurosurveillance.
Two other health workers may have had similar exposure after treating the UK's second monkeypox patient.
More than 100 governments, drug firms, and others have already made commitments.
